Prognostic Biomarkers in Patients With Urothelial Carcinoma

Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic

NCT04770974 ·Status: UNKNOWN

Basal Like Bladder Cancer : Signature and Therapeutic

NCT02648100 ·Status: UNKNOWN

Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer

NCT04726735 ·Status: COMPLETED

Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma

NCT05139134 ·Status: UNKNOWN

Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma

NCT00867620 ·Status: UNKNOWN

A Diagnostic for the Early Detection of Bladder Cancer

NCT05347342 ·Status: ACTIVE_NOT_RECRUITING

Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma

NCT04701918 ·Status: COMPLETED ·Phase: PHASE2

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

NCT01050504 ·Status: RECRUITING

Bladder Cancer Patient-Reported Outcomes

NCT01090388 ·Status: COMPLETED

Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy

NCT06986304 ·Status: RECRUITING

Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

NCT02203136 ·Status: COMPLETED

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

NCT06350734 ·Status: ACTIVE_NOT_RECRUITING

Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool

NCT06878027 ·Status: RECRUITING

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder

NCT06289283 ·Status: ACTIVE_NOT_RECRUITING

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

NCT03413982 ·Status: RECRUITING

Study on the Staging and Prognosis Model of Bladder Cancer

NCT06565923 ·Status: ACTIVE_NOT_RECRUITING

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

NCT06567743 ·Status: RECRUITING ·Phase: PHASE2

Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health

NCT00776178 ·Status: COMPLETED

A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer

NCT02387996 ·Status: COMPLETED ·Phase: PHASE2

Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome

NCT04625556 ·Status: RECRUITING

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.

NCT06289270 ·Status: RECRUITING

First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma

NCT03324282 ·Status: TERMINATED ·Phase: PHASE2

Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer

NCT01776138 ·Status: COMPLETED

Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue

NCT02379429 ·Status: RECRUITING

Prospective Collection of Samples for Urothelial Cancer of Bladder

NCT04167332 ·Status: NOT_YET_RECRUITING